Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trialJeffrey L. Lennox, Peter Sklar, Richard B. Pollard et al.|The Lancet|2009Cited by 620
Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1Jeffrey L. Lennox, Raphael J. Landovitz, Heather J. Ribaudo et al.|Annals of Internal Medicine|2014Cited by 260